The impact of dietary patterns and the commensal microbiome on susceptibility to and severity of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has been largely ignored to date. In this Perspective, we present a rationale for an urgent need to investigate this possible impact and therapeutic options for COVID-19 based on dietary and microbiome modifications. The mitigating role of nanotechnology with relation to the impact of SARS-CoV-2 virus is highlighted.

Page 5181. In the sentence “Importantly, Prevotella has been abundantly seen in the clinical samples of SARSCoV- 2 infected patients,11−13...” the references should be 13−15 instead of 11−13. In Figure 1 and in the main text, anytime the term “SARCoV- 2” is used, it should be replaced with “SARS-CoV-2”.